Children ≤18 years of age receiving a pleural drainage procedure for complicated pneumonia were eligible if they were discharged from participating hospitals between January 1, 2004 and June 30, 2009.

In a retrospective analysis of 540 consecutive patients undergoing medical thoracoscopy, septations were observed in 60% of the cases and obstructed two thirds or more of the view in 15% of the cases, ...

Unlike current approaches that require frequent outpatient drainage through an externalized catheter or prolonged hospitalization for invasive pleurodesis procedures, Pleural Dynamics' Automatic ...

US-based device start-up Pleural Dynamics has treated the first patient in a clinical trial evaluating its fully implantable automatic effusion shunt for patients with pleural effusions, a buildup of ...

Resuscitation of patient is the first step in the treatment of pleural effusion. Thoracentesis may be used as a therapeutic aid in removing fluid and allowing the lung to expand and function. The ‘ABC ...

MINNEAPOLIS--(BUSINESS WIRE)--Pleural Dynamics, a medical device company that is building solutions for recurrent fluid collections in the body, announced today that the final patient in “The ACES™ ...

Boerhaave syndrome is a pressure-induced rupture of the esophageal wall and is associated with high morbidity and mortality. 1,2 Due to the rapid development and severe clinical course of Boerhaave ...

CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN). This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.

Author Ram Gulrajani, BSc, Asthma Dip, COPD Dip, RSCN, RGN, is respiratory nurse specialist, West Essex PCT. Abstract Gulrajani, R. (2008) Avoiding hospital admission to drain pleural effusions. This ...

Chest Drainage System Market Analysis by Pleural Drainage Systems and Pleural Drainage System Kits, 2023 to 2033. Analyzing Emerging Trends and Opportunities for Chest Drainage Systems Manufacturers ...

TOKYO & AUSTIN, Texas--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd, (“Taiho”) and Lung Therapeutics, Inc. (“Lung Tx”) announced today an exclusive license agreement of LTI-01, a recombinant human ...

This multicenter study is the largest to evaluate the management of children hospitalized with complicated pneumonia. We found considerable variation in initial management and outcomes across ...